EUVIMEDOntdek EUVIMED
Open access · CC BY-NC 4.0

Survey of Post‐Prophylaxis Delayed‐Onset Cytomegalovirus Management Strategies Among Transplant Providers

Lemuel R Non iD, Chen Sabrina Tan, Dilek Ince iD, Raymund R Razonable

Clinical Transplantation · 2024

DOI: 10.1111/ctr.70015 ↗

At a glance

Journal article in Clinical Transplantation, 2024. Written by Lemuel R Non and 3 co-authors. Institution: Division of Infectious Diseases, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA. Major MEDLINE topics: Cytomegalovirus Infections, Organ Transplantation, Cytomegalovirus, Antiviral Agents. Cited 2 times so far (Crossref); 12 references. The full text is freely available (open access, CC BY-NC 4.0).

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

Background

Preventive strategies for cytomegalovirus (CMV) in the posttransplant period have changed the pattern of CMV infections, now more commonly manifesting as late‐onset occurrences known as post‐prophylaxis delayed‐onset CMV disease (PPDOC). We conducted a survey to investigate provider practices in managing PPDOC.

Methods

A web‐based provider survey on the management of PPDOC was developed using Research Electronic Data Capture (REDCap). It was distributed to the online forums of the American Society of Transplantation communities of practice (COP) for Infectious Diseases (IDCOP), Kidney and Pancreas (KPCOP), Liver and Intestinal (LICOP), and Thoracic and Critical Care (TCCOP). The survey was posted twice within a span of a month.

Results

Fifty‐six respondents, comprising 50 (89%) transplant physicians and 6 (11%) transplant pharmacists, from 46 distinct transplant centers, completed the survey. Universal antiviral prophylaxis (UAP) was the predominant preventive approach for both high‐risk (85%) and moderate‐risk (85%) transplant recipients. Out of 56, 51 respondents completed the questions regarding management of PPDOC. Regular surveillance with nucleic acid amplification tests (NAAT) (88%) was the most commonly used approach in high‐risk recipients, while symptom monitoring (73%) was the most common strategy in moderate‐risk recipients. Immunologic monitoring was used only by a few respondents who found it moderately useful in high‐risk recipients.

Conclusion

Management of PPDOC was highly variable among providers and strategies differed based on patient risk profile. These findings could help shape future studies and guidelines to harmonize CMV management.

Subjects

MeSH terms (MEDLINE)

Cytomegalovirus InfectionsOrgan TransplantationCytomegalovirusAntiviral AgentsHumansSurveys and QuestionnairesPrognosisDisease ManagementPractice Patterns, Physicians'Follow-Up StudiesPostoperative ComplicationsGraft RejectionFemaleMalePost-Exposure Prophylaxis

Substances

Antiviral Agents

Authors and institutions

  • Division of Infectious Diseases, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
  • Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA.

ORCID profiles: Lemuel R Non, Dilek Ince

Cite

APA

Non, L. R., Tan, C. S., Ince, D., & Razonable, R. R. (2024). Survey of Post‐Prophylaxis Delayed‐Onset Cytomegalovirus Management Strategies Among Transplant Providers. Clinical Transplantation. https://doi.org/10.1111/ctr.70015

Vancouver

Non LR, Tan CS, Ince D, Razonable RR. Survey of Post‐Prophylaxis Delayed‐Onset Cytomegalovirus Management Strategies Among Transplant Providers. Clinical Transplantation. 2024. doi:10.1111/ctr.70015

BibTeX
@article{Non2024,
  author = {Non, Lemuel R and Tan, Chen Sabrina and Ince, Dilek and Razonable, Raymund R},
  title = {Survey of Post‐Prophylaxis Delayed‐Onset Cytomegalovirus Management Strategies Among Transplant Providers},
  journal = {Clinical Transplantation},
  year = {2024},
  doi = {10.1111/ctr.70015}
}
Start for free →